Healthy Aging & Longevity
Chronic Fatigue & Low Energy
Persistent fatigue not explained by simple causes.
About this condition
Fatigue has many causes. We investigate thoroughly before recommending cellular or metabolic support.
How we approach it
We start with biomarker and genomic testing to understand your baseline, then build a protocol measured against those same markers at follow-up.
Therapies we may consider
How to prepare
- •Gather your records: diagnosis letters, recent lab results, imaging reports (MRI, X-ray, CT) and a medication list.
- •Keep taking prescribed medication — we never ask you to stop treatment from your own doctor.
- •Ask your specialist whether they are willing to share notes with our physicians; coordinated care is safer.
- •Write down your main goals and current symptoms (for example, pain on a 0–10 scale or walking distance) so we can measure change honestly.
- •Plan your trip: most programs need 2–5 days in Los Cabos, and you should avoid long flights for 24 hours after joint procedures if possible.
Possible side effects
Depends on the therapy your physician recommends. Most are mild and short-lived.
Peptide & NAD+ Protocols
- · During NAD+ infusion: chest tightness, flushing, nausea, cramping or headache — these usually settle quickly when the drip is slowed
- · Injection-site redness for peptides
- · Mild fatigue
Hyperbaric & Red Light
- · Ear pressure or discomfort (most common with HBOT)
- · Temporary sinus pressure
- · Fatigue after sessions
- · Temporary short-sightedness during long HBOT series, which normally resolves weeks after finishing
Selected published research
Allogeneic MSCs ameliorate aging frailty: a phase II randomized, placebo-controlled trial
Tompkins BA et al., J Gerontol A, 2017
Improvements in walking distance and inflammatory markers compared with placebo.
HBOT increases telomere length and decreases immunosenescence
Hachmo Y et al., Aging, 2020
Markers of cellular ageing improved in older adults after a 60-session HBOT course.
Nicotinamide riboside elevates NAD+ in middle-aged and older adults
Martens CR et al., Nat Commun, 2018
NAD+ levels rose and supplementation was well tolerated.
Links open PubMed or the original source. Study results do not guarantee individual outcomes.
What the evidence says
Therapies are used as supportive care alongside — never instead of — your existing medical treatment.
We do not promise cures or specific outcomes. Read our safety & eligibility page.
Wondering if you're a candidate?
A physician will review your records and give you an honest answer.
Book a Consultation